Regenerative Medicine Market By Technology (Small Molecules And Biologics, Gene Therapy, Cell Therapy), By Application (Dermatology, Cardiovascular Disorders, Central Nervous System (CNS), Orthopedic, Dental), Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Jul 31, 2016

Report Description


The regenerative medicine market is expected to grow with a robust CAGR of 14% in the forecast period of 2016 to 2022. In 2015, the market has generated the revenue of $ 3.85 billion and is expected to reach up to $9.64 billion by 2022. The fast growing advancements in stem cell technology; thepotentialsof nanotechnology; and,rising cases of chronic diseases and trauma injuriesare the major drivers for the regenerative medicine,globally.The increasing demand and awareness of steam cells also helps to increase themarket forregenerative medicine. In Europe,more than 80%of European citizens support embryonic stem cell research, while 84%support non-embryonic stem cell research; and,67% supported research with human embryonic stem cells. Similarly, in UK 57% people feel the benefits of stem cell research outweigh any potential risks;90%ofpeopleknows of “stem cells”, but only 34% felt “well-informed” about them. Similarly,in Germany it was analyzed that 92.5% of respondents were aware of stem cells;73.8% support increased funding for stem cell research;83.5% support use of stem cells to treat patients; and,67.8% support use of tissue stem cells for research. This increasing demand of cell and tissues is expected to increase the market of regenerative medicine,globally. The rising chronic cases also become the key driver for regenerative medicine market. According to a World Health Organizationsreport, the cancer rate is estimated to increase by 50% to 15 million new cases by 2020.Brest cancer is one of the most common type of cancer cases among women’s in both developed and developing countries. It has been recorded, that more than 1.7 million new breast cancer cases came among women worldwide, in 2014; 870,000 cases of stomach cancer; 560,000 cases of cervical cancer; and, 410,000 cases of head and neck, among many others. The increasing number of cancer cases day by day has increased the demand of cell and tissue, and is expected to further boost the market in the future. The lung cancer is the most common type of cancer among men, globally. According to the World Health Organization,it has been recorded that, in 2014 more than 1.3 million new cancer cases came among the men, globally.The increasing applications of stem cells and high potentials of marketsin developing nations are some opportunities which increase the market forregenerative medicine. Also, the growing number of cancer cases every year in developing region are increasing the market of regenerative medicine. It is estimated that in India,the number of cancer cases will reach up to 1,148,757 by 2020. The tobacco-related cancers cases for males are projected to reach up to 225,241 in the year 2020. Similarly, for females,various cancer cases will go up to 93,563 in the Year 2020. Gynecological-related cancers cases are anticipated to go up to 182,602 by 2020. Among males and females, breast cancer alone is anticipated to cross the figure of 100,000 by the year 2020. The increasing number of cancer cases in India is increasing the demand of regenerative medicine which increases the market forregenerative medicine in India. The government regulations and policies that are laid down to maintain the standards for biopharmaceuticals, pharmaceuticals and for cell and tissues therapeutics exist in the US, India, and other nations. Most of the governments basic regulations were interpreted to frame a basic legal out-look to make inviting lengthy and difficult regulatory process. This has become a major hindrance for the market, which delays the production time and restricts the market growth.


The market forregenerative medicine is segmented on the basis of technology and application. On the basis of technology, the market of regenerative medicine is segmented intoSmall Molecules and Biologics; Gene Therapy; and, Cell Therapy. On the basis of application, the market for regenerative medicine is segmented into Dermatology; Cardiovascular Disorders; Central Nervous System; Orthopedic; and, Dental.


Geographically, the market forregenerative medicine is segmented in to North America, Asia pacific, Europe and rest of the world. North America dominates the global regenerative medicine market owing to the rising demand for bone and joint reconstructive surgeries. The countries increasing aging population is predicted to drive the Europe regenerative medicine market in the next few years. Moreover, Asia Pacific is projected to register considerable growth in the global regenerative medicine market.


Some of the major market players are Advanced Cell Technology, Inc.;Athersys, Inc.;Cellerant Therapeutics, Inc.;Cytomedix, Inc.;Cytori Therapeutics, Inc.;Embryome Sciences, Inc.;Genzyme; Kinetic Concepts, Inc.;Mesoblast Ltd.;Neurologix, Inc.;NuVasive Inc.;OncoMed Pharmaceuticals;Pieris AG;Shire Pharmaceuticals; Stem cells, Inc.Acquisitions, innovations and mergers are the key strategies adopted by the market players to sustain in the market. For examples:in January 2016, Healios K.K. and Athersys, Inc. have announced a partnership and license agreement that will emphasis the development and commercialization of novel cell therapy treatments, with MultiStem® for the treatment of ischemic strokes and potentially other indications, in Japan.

1. Introduction
1.1. Executive summary
1.2. Estimation methodology


2. Market overview
2.1. Market definition and scope
2.2. Key findings
2.3. Parametric analysis
2.3.1. Production geographically
2.3.2. Adoption across various industries
2.4. Key market insights
2.4.1. Top emerging countries
2.4.2. Top revenue generating segments
2.4.3. Top growing markets and emerging trends
2.5. Competitive Landscape
2.5.1. Market share analysis
2.5.2. Top winning strategies
2.6. Porter’s Five Force Model
2.6.1. Threat of New Entrants
2.6.2. Threat of Substitute Products or Services
2.6.3. Bargaining Power of Buyer
2.6.4. Bargaining Power of Supplier
2.6.5. Intensity of Competitive Rivalry
2.7. Key buying criteria
2.8. Strategic recommendation
2.9. Strategic conclusions


3. Market determinants
3.1. Market drivers
3.1.1. Advancements in Stem Cell Technology
3.1.2. Potentials of Nanotechnology
3.1.3. Rising Cases of Chronic Diseases and Trauma Injuries
3.2. Market restraints
3.2.1. Strict Regulatory Policies and Ethical Issues
3.2.2. High Expensive treatment
3.3. Market opportunities
3.3.1. Increasing Applications of Stem Cells
3.3.2. High Market in Developing Nations
3.4. Market challenges
3.4.1. Continuation for New Entrants and Small Players
3.5. Parent Market
3.6. Competitors Market
3.7. Alternative Market


4. Market Segmentation
4.1. By technology
4.1.1. Global Regenerative Medicine market by Small Molecules and Biologics 2014-2022 ($ Million)
4.1.2. Global Regenerative Medicine market by Gene Therapy 2014-2022 ($ Million)
4.1.3. Global Regenerative Medicine market by Cell Therapy 2014-2022 ($ Million)
4.2. By Application
4.2.1. Global Regenerative Medicine Market by Dermatology 2014-2022 ($ Million)
4.2.2. Global Regenerative Medicine Market by Cardiovascular Disorders 2014-2022 ($ Million)
4.2.3. Global Regenerative Medicine Market by Central Nervous System (CNS) 2014-2022 ($ Million)
4.2.4. Global Regenerative Medicine Market by Orthopedic 2014-2022 ($ Million)
4.2.5. Global Regenerative Medicine Market by Dental 2014-2022 ($ Million)
4.2.6. Global Regenerative Medicine Market by Others 2014-2022 ($ Million)
4.2.6.1. Global Regenerative Medicine Market by Autoimmune Diseases2014-2022 ($ Million)
4.2.6.2. Global Regenerative Medicine Market by Muscle regeneration2014-2022 ($ Million)
4.2.6.3. Global Regenerative Medicine Market by Ocular Diseases2014-2022 ($ Million)
4.2.6.4. Global Regenerative Medicine Market by Internal organ regeneration2014-2022 ($ Million)


5. Geographical Analysis
5.1. North America Regenerative MedicineMarket 2014-2022 ($ Million)
5.1.1. United States (U.S.) Regenerative MedicineMarket 2014-2022 ($ Million)
5.1.2. Canada Regenerative MedicineMarket 2014-2022 ($ Million)
5.2. Europe Regenerative MedicineMarket 2014-2022 ($ Million)
5.2.1. United Kingdom (UK) Regenerative MedicineMarket 2014-2022 ($ Million)
5.2.2. France Regenerative MedicineMarket 2014-2022 ($ Million)
5.2.3. Germany Regenerative MedicineMarket 2014-2022 ($ Million)
5.2.4. Spain Regenerative MedicineMarket 2014-2022 ($ Million)
5.2.5. Italy Regenerative MedicineMarket 2014-2022 ($ Million)
5.2.6. ROE Market2014-2022 ($ Million)
5.3. Asia Pacific Regenerative MedicineMarket 2014-2022 ($ Million)
5.3.1. India Regenerative MedicineMarket 2014-2022 ($ Million)
5.3.2. China Regenerative MedicineMarket 2014-2022 ($ Million)
5.3.3. Japan Regenerative MedicineMarket 2014-2022 ($ Million)
5.3.4. Korea Regenerative MedicineMarket 2014-2022 ($ Million)
5.3.5. Australia Regenerative MedicineMarket 2014-2022 ($ Million)
5.3.6. ROAPAC Regenerative MedicineMarket 2014-2022 ($ Million)
5.4. Rest Of The World Regenerative MedicineMarket 2014-2022 ($ Million)
5.4.1. Latin America Regenerative MedicineMarket 2014-2022 ($ Million)
5.4.2. MENA Regenerative MedicineMarket 2014-2022 ($ Million)
5.4.3. Africa Regenerative MedicineMarket 2014-2022 ($ Million)


Company Profiling: (Over, SCOT Analysis, Strategic Review)
1. Advanced Cell Technology, Inc.
2. Athersys, Inc.
3. Cellerant Therapeutics, Inc.
4. Cytomedix Inc.
5. Cytori Therapeutics, Inc.
6. Embryome Sciences, Inc.
7. Genzyme
8. Kinetic Concepts, Inc.
9. Mesoblast Ltd.
10. Neurologix, Inc.
11. NuVasive Inc.
12. OncoMed Pharmaceuticals
13. Pieris AG
14. Shire Pharmaceuticals
15. Stem cells, Inc.

1. Global Regenerative Medicineby Technology 2014-2022 ($ Million)
2. Global Regenerative MedicineMarket by Cloud Computing 2014-2022 ($ Million)
3. Global Regenerative MedicineMarket by Cloud Storage 2014-2022 ($ Million)
4. Global Regenerative MedicineMarket by Internet Technologies 2014-2022 ($ Million)
5. Global Regenerative Medicine Market byEnd User 2014-2022 ($ Million)
6. Global Regenerative Medicine Market byManufacturer 2014-2022 ($ Million)
7. Global Regenerative Medicine Market byAutomobile 2014-2022 ($ Million)
8. Global Regenerative Medicine Market byHealth Care 2014-2022 ($ Million)
9. Global Regenerative Medicine Market byTransportation 2014-2022 ($ Million)
10. Global Regenerative Medicine Market byConsumer Services 2014-2022 ($ Million)
11. Global Regenerative Medicine Market byOthers 2014-2022 ($ Million)
12. North America Regenerative MedicineMarket 2014-2022 ($ Million)
13. Europe Regenerative MedicineMarket 2014-2022 ($ Million)
14. Asia Pacific Regenerative MedicineMarket 2014-2022 ($ Million)
15. Rest of the World Regenerative MedicineMarket 2014-2022 ($ Million)

1. Global Regenerative Medicineby Technology 2014-2022 ($ Million)
2. Global Regenerative MedicineMarket by Cloud Computing 2014-2022 ($ Million)
3. Global Regenerative MedicineMarket by Cloud Storage 2014-2022 ($ Million)
4. Global Regenerative MedicineMarket by Internet Technologies 2014-2022 ($ Million)
5. Global Regenerative Medicine Market byEnd User2014-2022 ($ Million)
6. Global Regenerative Medicine Market byManufacturer 2014-2022 ($ Million)
7. Global Regenerative Medicine Market byAutomobile 2014-2022 ($ Million)
8. Global Regenerative Medicine Market byHealth Care 2014-2022 ($ Million)
9. Global Regenerative Medicine Market byTransportation 2014-2022 ($ Million)
10. Global Regenerative Medicine Market byConsumer Services 2014-2022 ($ Million)
11. Global Regenerative Medicine Market byOthers 2014-2022 ($ Million)
12. United States (U.S.) Regenerative MedicineMarket 2014-2022 ($ Million)
13. Canada Regenerative MedicineMarket 2014-2022 ($ Million)
14. United Kingdom (UK) Regenerative MedicineMarket 2014-2022 ($ Million)
15. France Regenerative MedicineMarket 2014-2022 ($ Million)
16. Germany Regenerative MedicineMarket 2014-2022 ($ Million)
17. Spain Regenerative MedicineMarket 2014-2022 ($ Million)
18. Italy Regenerative MedicineMarket 2014-2022 ($ Million)
19. ROE Market 2014-2022 ($ Million)
20. India Regenerative MedicineMarket 2014-2022 ($ Million)
21. China Regenerative MedicineMarket 2014-2022 ($ Million)
22. Japan Regenerative MedicineMarket 2014-2022 ($ Million)
23. Korea Regenerative MedicineMarket 2014-2022 ($ Million)
24. Australia Regenerative MedicineMarket 2014-2022 ($ Million)
25. ROAPAC Regenerative MedicineMarket 2014-2022 ($ Million)
26. Latin America Regenerative MedicineMarket 2014-2022 ($ Million)
27. MENA Regenerative MedicineMarket 2014-2022 ($ Million)
28. Africa Regenerative MedicineMarket 2014-2022 ($ Million)

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)